Nuclear Pore Protein p62 Autoantibodies in Systemic Lupus Erythematosus

Table 1: Clinical Disposition and Anti-p62 Antibodies in 25 Patients Suffering from SLE and Two Healthy Controls (C1 and C2)

Pat	Age	Sex	Kidney Disease	Neurologic Disorder	Arthritis/Arthralgia	Skin Disease	Haematology Disease	Musculosceletal Disorder	Vascular Disease	ANAs	Anti DNS	Anti-p62	SLICC/SDI
C1	41	f								-	-	-	0
C2	24	f								-	-	-	0
1	29	f		+,+	⁺	⁽⁺⁾				-	⁺	++	3
2	49	f			⁽⁺⁾	⁽⁺⁾			⁺	⁺	⁺	-	1
3	29	f			⁽⁺⁾	⁺				⁺	⁺	-	1
4	32	f			⁽⁺⁾					-	⁺	-	0
5	30	f		⁽⁺⁾						-	⁺	-	0
6	38	f	^N^{, (+)}, ^P^{, (+)}		⁽⁺⁾	⁽⁺⁾	⁽⁺⁾			⁺	⁺	-	0
7	34	f	^P^{, (+)}		⁽⁺⁾	⁽⁺⁾	⁽⁺⁾		⁽⁺⁾	⁺	⁺	-	0
8	36	f	^P^{, (+)}	+,+	⁽⁺⁾	⁽⁺⁾		⁽⁺⁾		⁺	⁺	-	2
9	57	f	⁽⁺⁾		⁽⁺⁾		⁽⁺⁾			-	⁺	-	0
10	57	m		⁺	⁽⁺⁾	⁽⁺⁾	⁽⁺⁾			⁺	⁺	-	1
11	39	f	^P^{, (+)}		⁽⁺⁾	⁺	⁽⁺⁾			-	⁺	⁺	1
12	42	f			⁽⁺⁾		⁽⁺⁾			⁺	⁺	-	0
13	36	f	^N^{, (+)}		⁺					⁺	⁺	-	1
14	40	f			⁽⁺⁾	⁽⁺⁾				-	⁺	-	0
15	56	f	^P^{, (+)}	⁺			⁽⁺⁾			⁺	⁺	-	1
16	40	f	^P^{, (+)}		⁺	⁽⁺⁾				-	⁺	-	1
17	24	f	^P^{, (+)}				⁽⁺⁾			-	⁺	+++	0
18	63	f		⁺			⁽⁺⁾			⁺	-	-	1
19	32	m					⁽⁺⁾			⁺	⁺	-	0
20	27	f	^N^{, (+)}	⁺	⁽⁺⁾	⁽⁺⁾	⁽⁺⁾			⁺	⁺	-	1
21	35	m	^N^{, (+)}		⁽⁺⁾	⁽⁺⁾				-	⁺	++	0
22	41	f					⁽⁺⁾			-	⁺	-	0
23	46	f	^N^{, (+)}		⁽⁺⁾		⁽⁺⁾		⁽⁺⁾	⁺	⁺	-	0
24	64	f	^N^{, (+)}, ^P^{, +}		⁽⁺⁾	⁽⁺⁾	⁽⁺⁾	⁽⁺⁾		-	-	+++	1
25	46	f	^N^{, +}		⁺	⁽⁺⁾	⁽⁺⁾			⁺	⁺	++	2

The table shows numbered index of patients (Pat), age, gender, organ disease, p62-autoantibodies and the SLICC/SDI Damage Score for each patient.

⁽⁺⁾ symptoms without organ damage,

⁺ organ damage,

^N nephritis,

^P proteinuria.